Specific Deficiencies versus Growth Failure: Type I and Type Ii Nutrients
Golden, M.H.N.
Journal of Nutritional and Environmental Medicine 6(3): 301-308
1996
DOI: 10.3109/13590849609007256Document Number: 291232
Document emailed within 0-6 h
Related Documents
Bhargava, P.M.; Dwarakanath, V.N.; Prasad, K.S. 1979: Regulation of cell division and malignant transformation through control of uptake of essential nutrients. Demonstration of the presence in rat liver of a new type of protein inhibitor of transport of such nutrients Cellular and Molecular Biology Including Cyto-Enzymology 25(2): 85-94Pellegrino, M.G.; Bluth, M.H.; Smith-Norowitz, T.; Fikrig, S.; Volsky, D.J.; Moallem, H.; Auci, D.L.; Nowakowski, M.; Durkin, H.G. 2002: HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro Aids Research and Human Retroviruses 18(5): 363-372
Anthony, D.D.; Heeger, P.S.; Haqqi, T.M. 2001: Immunization with TCR Vbeta10 peptide reduces the frequency of type-Ii collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice Clinical and Experimental Rheumatology 19(4): 385-394
Gay, S.; Remberger, K.; Adelmann, B.C. 1975: Immunofluorescence microscopy studies with isolated type-specific antibodies against collagen type I, Ii and IIi in connective tissue diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1183-1185
Thakar, M.R.; Patke, D.; Lakhashe, S.K.; Bhonge, L.; Kulkarni, S.V.; Tripathy, S.P.; Gupte, N.; Brookmeyer, R.; Quinn, T.C.; Paranjape, R.S.; Bollinger, R.C. 2002: Consistent subtype-specific anti-HIV type 1 T lymphocyte responses in Indian subjects recently infected with HIV type 1 Aids Research and Human Retroviruses 18(18): 1389-1393
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957
Erzen, M.; Stanescu, R.; Stanescu, V.; Maroteaux, P. 1988: Comparative histopathology of the growth cartilage in short-rib polydactyly syndromes type i and type IIi and in chondroectodermal dysplasia Annales de Genetique 31(3): 144-150
Barski, G.; Youn, J.K.; Belehradek, J.; Le François, D. 1972: Variations of cellular type specific immunological defense mechanisms as a function of tumor growth Annales de l'Institut Pasteur 122(4): 633-643
Stepan, V.M.; Dickinson, C.J.; del Valle, J.; Matsushima, M.; Todisco, A. 1999: Cell type-specific requirement of the MAPK pathway for the growth factor action of gastrin American Journal of Physiology 276(6): G1363-G1372
Pucci-Minafra, I.; Luparello, C. 1991: Type V/type i collagen interactions in vitro and growth-inhibitory effect of hybrid substrates on 8701-BC carcinoma cells Journal of Submicroscopic Cytology and Pathology 23(1): 67-74
Head, M.K.; Weeks, R.J. 1975: Major nutrients in the Type a lunch. II. Amounts consumed by students Journal of the American Dietetic Association 67(4): 356-360
Meyer, D.H.; Bachem, M.G.; Gressner, A.M. 1990: Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha Biochemical and Biophysical Research Communications 171(3): 1122-1129
Peerapatdit, T.; Patchanans, N.; Likidlilid, A.; Poldee, S.; Sriratanasathavorn, C. 2006: Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients Journal of the Medical Association of Thailand 89(Suppl 5): S147-S155
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
McKean, D.J.; Podzorski, R.P.; Bell, M.P.; Nilson, A.E.; Huntoon, C.J.; Slack, J.; Dower, S.K.; Sims, J. 1993: Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity Journal of Immunology 151(7): 3500-3510
Antonaci, S.; Jirillo, E.; Garofalo, A.R.; Polignano, A.; Resta, F.; Pugliese, P.; Capurso, A.; Bonomo, L. 1988: Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia Cytobios 54(218-219): 181-189
Chen, C.-Y.; He, S.-Z.; Hu, B.; Lü, W.-L. 2012: Effects of land use type on spatiotemporal distribution of soil nutrients in Dianchi watershed, Yunnan Province of Southwest China Ying Yong Sheng Tai Xue Bao 23(10): 2677-2684
Berntorp, E.; Jarevi, G.; Vedback, A.; Nilsson, I.M. 1986: Living adenovirus type 4 vaccine human t lymphotropic virus type iii antibodies in swedish hemophiliacs in relation to type and dosage of factor concentrate Thrombosis Research (Suppl 6): 18
Stenner, E.; Buiatti, A.; Barbati, G.; Merlo, M.; Sinagra, G.; Biasioli, B. 2012: Comparative Evaluation of B-Type Natriuretic Peptide and Mid-Regional Pro-A-Type Natriuretic Peptide Changes from Admission to Discharge in Prognosis of Acute Decompensated Heart Failure Patients Clinical Laboratory 58(5-6): 585-589
Schulte-Hermann, R.; Parzefall, W. 1981: Failure to discriminate initiation from promotion of liver tumors in a long-term study with the phenobarbital-type inducer alpha-hexachlorocyclohexane and the role of sustained stimulation of hepatic growth and monooxygenases Cancer Research 41(10): 4140-4146